Literature DB >> 26429870

Cardiorespiratory and sensory responses to exercise in adults with mild cystic fibrosis.

Bradley S Quon1, Sabrina S Wilkie2, Yannick Molgat-Seon3, Michele R Schaeffer4, Andrew H Ramsook4, Pearce G Wilcox1, Jordan A Guenette5.   

Abstract

The purpose of this study was to evaluate cardiorespiratory fitness and reasons for exercise curtailment in a contemporary adult cystic fibrosis (CF) cohort with mild lung disease. Adults with mild CF (n = 19, forced expiratory volume in 1 s = 95 ± 17% predicted) were age-, sex-, ethnicity-, and body mass index-matched to healthy controls (n = 19) and underwent a detailed cardiopulmonary cycle exercise test. While CF subjects had a reduced peak oxygen uptake compared with controls, the values were normal when expressed as %predicted in 14/19 (74%) of subjects. Both groups demonstrated a normal cardiovascular limitation to exercise and stopped exercise primarily because of leg fatigue. Despite not being exercise-limited by respiratory factors, there was some evidence of ventilatory abnormalities as patients with mild CF had increased end-inspiratory lung volumes and reached an inflection/plateau in tidal volume relative to minute ventilation at lower exercise intensities compared with controls. Subjects with CF were not more likely to demonstrate expiratory flow limitation compared with controls and did not have evidence of dynamic hyperinflation during exercise. Despite increased end-inspiratory lung volumes and an earlier tidal volume inflection/plateau, CF subjects did not experience higher levels of dyspnea. In an exploratory analysis, a significant inverse correlation was observed between sweat chloride and peak work rate. Adult CF subjects with relatively well preserved spirometry have normal exercise performance relative to reference values and are primarily limited by nonrespiratory factors. However, ventilatory abnormalities were detected even in this mild CF cohort and should be evaluated in future therapeutic trials focused on disease-modifying therapies in mild CF.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  dynamic hyperinflation; dyspnea; exercise limitation; expiratory flow limitation; ventilatory responses

Mesh:

Year:  2015        PMID: 26429870      PMCID: PMC4669346          DOI: 10.1152/japplphysiol.00692.2015

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  42 in total

1.  Assessment of fitness in patients with cystic fibrosis and mild lung disease.

Authors:  P McLoughlin; D McKeogh; P Byrne; G Finlay; J Hayes; M X FitzGerald
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

2.  Regulation of ventilatory capacity during exercise in asthmatics.

Authors:  B D Johnson; P D Scanlon; K C Beck
Journal:  J Appl Physiol (1985)       Date:  1995-09

3.  Ventilation Distribution Heterogeneity at Rest as a Marker of Exercise Impairment in Mild-to-Advanced COPD.

Authors:  J Alberto Neder; Conor D J O'Donnell; Julia Cory; Daniel Langer; Casey E Ciavaglia; Y Ling; Katherine A Webb; Denis E O'Donnell
Journal:  COPD       Date:  2014-09-17       Impact factor: 2.409

4.  Respiratory factors do not limit maximal symptom-limited exercise in patients with mild cystic fibrosis lung disease.

Authors:  Jonathan D Dodd; Sinead C Barry; Charles G Gallagher
Journal:  Respir Physiol Neurobiol       Date:  2005-10-05       Impact factor: 1.931

5.  Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis.

Authors:  Richard Kraemer; Andrea Blum; Andreas Schibler; Roland A Ammann; Sabina Gallati
Journal:  Am J Respir Crit Care Med       Date:  2004-11-05       Impact factor: 21.405

6.  Muscle function and resting energy expenditure in female athletes with cystic fibrosis.

Authors:  Hiran C Selvadurai; Jane Allen; Toos Sachinwalla; James Macauley; Cameron J Blimkie; Peter P Van Asperen
Journal:  Am J Respir Crit Care Med       Date:  2003-09-18       Impact factor: 21.405

7.  Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease?

Authors:  Roberto C Chin; Jordan A Guenette; Sicheng Cheng; Natya Raghavan; Naparat Amornputtisathaporn; Arturo Cortés-Télles; Katherine A Webb; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2013-06-15       Impact factor: 21.405

Review 8.  Evidence for a mitochondrial lesion in cystic fibrosis.

Authors:  B L Shapiro
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

9.  Inspiratory Capacity during Exercise: Measurement, Analysis, and Interpretation.

Authors:  Jordan A Guenette; Roberto C Chin; Julia M Cory; Katherine A Webb; Denis E O'Donnell
Journal:  Pulm Med       Date:  2013-02-07

10.  Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease.

Authors:  Jean Pastré; Anne Prévotat; Catherine Tardif; Carole Langlois; Alain Duhamel; Benoit Wallaert
Journal:  BMC Pulm Med       Date:  2014-04-30       Impact factor: 3.317

View more
  6 in total

1.  Neck inspiratory muscle activation patterns during well-controlled inspiration.

Authors:  Sohei Washino; Hiroaki Kanehisa; Yasuhide Yoshitake
Journal:  Eur J Appl Physiol       Date:  2017-08-19       Impact factor: 3.078

2.  Overall and differentiated sensory responses to cardiopulmonary exercise test in patients with cystic fibrosis: kinetics and ability to predict peak oxygen uptake.

Authors:  Mathieu Gruet; Laurent Mely; Jean-Marc Vallier
Journal:  Eur J Appl Physiol       Date:  2018-07-09       Impact factor: 3.078

3.  Expiratory flow limitation under moderate hypobaric hypoxia does not influence ventilatory responses during incremental running in endurance runners.

Authors:  Yinhang Cao; Yuhei Ichikawa; Yosuke Sasaki; Takeshi Ogawa; Tsutomu Hiroyama; Yasushi Enomoto; Naoto Fujii; Takeshi Nishiyasu
Journal:  Physiol Rep       Date:  2019-02

4.  Exercise capacity in patients with cystic fibrosis vs. non-cystic fibrosis bronchiectasis.

Authors:  Ronen Bar-Yoseph; Anat Ilivitzki; Dan M Cooper; Michal Gur; Gur Mainzer; Fahed Hakim; Galit Livnat; Zeev Schnapp; George Shalloufeh; Merav Zucker-Toledano; Yael Subar; Lea Bentur
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

5.  Short-term effects of Lumacaftor/Ivacaftor (Orkambi™) on exertional symptoms, exercise performance, and ventilatory responses in adults with cystic fibrosis.

Authors:  Bradley S Quon; Andrew H Ramsook; Satvir S Dhillon; Reid A Mitchell; Kyle G Boyle; Pearce G Wilcox; Jordan A Guenette
Journal:  Respir Res       Date:  2020-06-01

Review 6.  Fatigue in Chronic Respiratory Diseases: Theoretical Framework and Implications For Real-Life Performance and Rehabilitation.

Authors:  Mathieu Gruet
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.